Indomethacin

Catalog No.S1723

Indomethacin  Chemical Structure

Molecular Weight(MW): 357.79

Indomethacin is a nonselective COX1 and COX2 inhibitor with IC50 of 0.1 μg/mL and 5 μg/mL, respectively, used to reduce fever, pain, stiffness, and swelling.

Size Price Stock Quantity  
In DMSO USD 130 In stock
USD 97 In stock
Bulk Discount

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

Cited by 5 Publications

1 Customer Review

  • Indicated PN and MES spheres were shown expressing GFP under the control of a 7 × TCF/LEF optimal promoter cassette (7 × TOP) and constitutively expressed nuclear mCherry. PN 84 and MES 1123 were treated with Wnt3a (200 ng/ml), indomethacin (Indo; 20 μM), or a control (vehicle). Scale bar, 100 μm. Bar graph, quantification of fluorescent signal of GFP (TOP-GFP) versus mCherry (PGK-H2BmCherry). The percentage of GFP- and mCherry-positive spheres was determined by FACS.

    Nat Commun, 2016, 7:12885. Indomethacin purchased from Selleck.

Purity & Quality Control

Choose Selective COX Inhibitors

Biological Activity

Description Indomethacin is a nonselective COX1 and COX2 inhibitor with IC50 of 0.1 μg/mL and 5 μg/mL, respectively, used to reduce fever, pain, stiffness, and swelling.
Targets
COX1 [6] COX-2 [6]
0.28 μM 14 μM
In vitro

Indomethacin inhibits transcription of a beta-catenin/TCF-responsive reporter gene in a dose dependent manner. Indomethacin also downregulates the beta-catenin/TCF transcriptional target cyclin D1. Indomethacin attenuates the transcription of beta-catenin/TCF-responsive genes, by modulating TCF activity without disrupting beta-catenin/TCF complex formation. [1]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
HeLa cells NUTIfJNLTnWwY4Tpc44h[XO|YYm= MljpNlAhdWmwcx?= M1\J[WFod26rc4SgZYN1cX[rdImgZZQh[W6mcn;n[Y4hemWlZYD0c5IhMHWwa37ve44hd3KrZ3nuLUBmgHC{ZYPz[YQhcW5iSHXMZUBk\WyuczDjc{1mgHC{ZYPzbY5oKFCVQT2oRXJGMTRvTIXjNVMh[XO|ZYPz[YQh[XNiaX7keYN1cW:wIH;mJGRJXC2rbnT1Z4VlKGy3Y3nm[ZJie2ViYXP0bZZqfHliYX\0[ZIhOjBibXnud{BjgSCudXPp[oVz[XOnIILldI9zfGW{IHflcoUh[XO|YYmsJGVEPTB;MD6xOEBvVQ>? MkXCNlM1OzJyOUW=
J774 cells MUnGeY5kfGmxbjDhd5NigQ>? M1jZTGlvKH[rdILvJIlvcGmkaYTvdpkh[WO2aY\peJkh[WejaX7zeEBRem:|dHHncIFv\GmwIFevTEB{gW62aHHz[UAyKGmwIH31dolv\SCMN{e0JINmdGy|LDDJR|UxRTJibl2= MVOxOVg2PzF2OR?=
U-937 cells MnPhSpVv[3Srb36gZZN{[Xl? MXLJckB3cXS{bzDpcohq[mm2b4L5JIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iUILvd5Ri\2yjbnTpckBIN0hic4nueIhie2ViMTCoR29ZNTFrIHnuJHUuQTN5IHPlcIx{NCCLQ{WwQVIhdk1? M3XKV|EzQDd5NUi0
rat synovial cells NHfEWllHfW6ldHnvckBie3OjeR?= MV7JckB3cXS{bzDpcohq[mm2b4L5JIVn\mWldDDvckBxem:mdXP0bY9vKG:oIIDyc5N1[WeuYX7kbY4hTTJiKGDHSVIqKGmwIILheEB{gW6xdnnhcEBk\WyuczygTWM2OD1{Lkmgcm0> M2LRclExQDJzN{G2
143982 cells MV\GeY5kfGmxbjDhd5NigQ>? MlLFTY4hfmm2cn:gbY5pcWKrdH;yfUBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIGDyc5N1[WeuYX7kbY4hTy:KIIP5cpRp[XOnIEKgLGNQYC1{KTDpckAyPDN7OEKgZ4VtdHNuIFnDOVA:QSCwTR?= MkDwNVI5Pzd3OES=
CHO cells NYPSc2lHTnWwY4Tpc44h[XO|YYm= M4f0dmlvKH[rdILvJIlvcGmkaYTvdpkheG:2ZX7jfUBi\2GrboP0JIh2dWGwIFPPXE0yKGmwIIP0ZYJtgSC2cnHud4Zm[3SnZDDjbIlv\XOnIHjhcZN1\XJib4\hdpkhMEOKTzmgZ4VtdHNuIFnDOVA:OThibl2= Mk\JNVA2PzZ4OES=
RBL-1 cell line Ml3VSpVv[3Srb36gZZN{[Xl? NGDQW3BKdmirYnn0bY9vKG:oIGDyc5N1[WeuYX7kbY4hTy:KIIP5cpRp[XOnIHnuJIlvfGGldDDSRmwuOSClZXzsJIxqdmVuIFnDOVA:OC53IN88US=> MWiyNVE2PTh4
SF-9 insect cells MVPGeY5kfGmxbjDhd5NigQ>? NVjYPZRIOjBiTXnudy=> MmW1TY5pcWKrdHnvckBw\iCqdX3hckBEV1h{IHX4dJJme3OnZDDpckBUTi17IHnud4VkfCClZXzsd{Bie3Onc4Pl[EBieyClb372[ZJ{cW:wIH;mJHsyPEOfLXHyZYNpcWSxbnnjJIFkcWRidH:gX|E1S11vcILvd5Ri\2yjbnTpcpMheHKnaX7jeYJifGWmIH\vdkAzOCCvaX7zJIJ6KHSqaX6tcIF6\XJiY3jyc41ifG:pcnHwbJkh[W6jbInzbZMtKEmFNUC9NE44PSEQvF2= NGHQOYczOTV{NEW4Oy=>
mouse RAW264.7 cells MlrxSpVv[3Srb36gZZN{[Xl? M3vhNlI1KGh? NWraXm81SW62aXnu[oxidW2jdH;yfUBi[3Srdnn0fUBqdiCvb4Xz[UBTSVd{NkSuO{Bk\WyuczDhd5Nme3OnZDDhd{BqdmirYnn0bY9vKG:oIFzQV{1qdmS3Y3XkJG5QKHC{b3T1Z5Rqd25iYX\0[ZIhOjRiaILzJIJ6KEe{aXXzd{Bie3OjeTygTWM2OD1zLkK1JO69VQ>? NIG1TY8zPDhyNkOxNC=>
mouse BV2 cells Ml\VSpVv[3Srb36gZZN{[Xl? NYLEVYpHOjRiaB?= MULBcpRqcW6obHHtcYF1d3K7IHHjeIl3cXS7IHnuJI1wfXOnIFLWNkBk\WyuczDhd5Nme3OnZDDhd{BqdmirYnn0bY9vKG:oIFzQV{1qdmS3Y3XkJG5QKHC{b3T1Z5Rqd25iYX\0[ZIhOjRiaILzJIJ6KEe{aXXzd{Bie3OjeTygTWM2OD15LkGg{txO M2TTU|I1ODR{MEC3
human 2008 cells NGfKcVBHfW6ldHnvckBie3OjeR?= NFfhNHhKdmirYnn0bY9vKG:oIHj1cYFvKE2UUEGgbY4hcHWvYX6gNlAxQCClZXzsd{whUUN3ME2xNkDPxE1? NYXkUItrOTh5MEe4PFQ>
A549 cells  M3\3b2Z2dmO2aX;uJIF{e2G7 MnrjNVAh|ryP MkPwTY5pcWKrdHnvckBw\iCvUFfFV|EhcW5iaIXtZY4hSTV2OTDj[YxteyCjc4Pld5Nm\CCjczDpcohq[mm2aX;uJI9nKEmOLUGtZoV1[S2rbnT1Z4VlKFCJRUKg[o9zdWG2aX;uJIF1KDFyIIXNJIJ6KGOnbHytbY51[WO2IHHzd4F6 M3vy[lE6ODV|N{Wx
HepG2 cells MYjGeY5kfGmxbjDhd5NigQ>? MYixNFAh|ryP MVXJcohq[mm2aX;uJI9nKE2UUEGtcYVlcWG2ZXSg[I95d3K3YnnjbY4h\W[obIX4JIlvKGSxeH;yeYJq[2mwIILld4l{fGGwdDDoeY1idiCKZYDHNkBk\WyuczDheEAyODBidV2gZpkh\myxdzDjfZRwdWW2com= NUC4W5ZiOjB2NUW1O|g>
THP1 cells M{\ld2Z2dmO2aX;uJIF{e2G7 Mm\JNVAxKM7:TR?= NHXVVGU{OCCvaX7z MlrOTZJz\X[ncoPpZoxmKGmwaHnibZRqd25ib3[gR29ZNTFiaX6gbJVu[W5iVFjQNUBk\WyuczDhd5Nme3OnZDDhd{BqdmirYnn0bY9vKG:oIHHyZYNpcWSxbnnjJIFkcWRvaX7keYNm\CCWWFKyJIZwem2jdHnvckBifCBzMECgeW0hcW6ldXLheIVlKG[xcjCzNEBucW6|IH\vcIxwf2WmIHL5JINwdXCxdX7kJJdie2ixdYSgcYVie3W{ZXSgN|AhdWmwczDwc5N1KGG{YXPobYRwdmmlIHHjbYQh[2ijbHzlcodmKGK7IILh[IlwcW2vdX7vZZN{[Xl? NIrDUY4zOzZ3MUO1PS=>
MDA-MB-231 cells NHK0VmxHfW6ldHnvckBie3OjeR?= NYG1eWdkOTByIN88US=> NXT3OppbOzBibXnudy=> NWrXdIp[UXK{ZY\ldpNq[mynIHnubIljcXSrb36gc4YhS0:[LUGgbY4hcHWvYX6gUWRCNU2ELUKzNUBk\WyuczDhd5Nme3OnZDDhd{BqdmirYnn0bY9vKG:oIHHyZYNpcWSxbnnjJIFkcWRvaX7keYNm\CCSR1WyJIZwem2jdHnvckBifCBzMECgeW0hcW6ldXLheIVlKG[xcjCzNEBucW6|IH\vcIxwf2WmIHL5JINwdXCxdX7kJJdie2ixdYSgcYVie3W{ZXSgN|AhdWmwczDwc5N1KGG{YXPobYRwdmmlIHHjbYQh[2ijbHzlcodmKGK7IILh[IlwcW2vdX7vZZN{[Xl? M3XSPVI{PjVzM{W5
LNCAP cells MVPGeY5kfGmxbjDhd5NigQ>? MVGzNEDPxE1? MUW0PEBp MV;Jcohq[mm2aX;uJI9nKEGNUkHDN{ApfW6tbn;3ckBwemmpaX6pMY1m\GmjdHXkJJRme3Sxc4Tldo9v\S1zN3LleIEu\2y3Y4Xyc45q\GViZn;ycYF1cW:wIHX4dJJme3OnZDDpckBpfW2jbjDMUmNCWCClZXzsd{BifCB|MDD1UUBi\nSncjC0PEBpenNiaX6gdJJme2WwY3Wgc4YhPC2jbnTyc5N1\W6nLUOsNVcu\GmxbnW= MXmyN|Q{OjB7NR?=
mouse BV2 cells MWXDfZRwfG:6aXPpeJkh[XO|YYm= MlXZNlQhcA>? MlTWR5l1d3SxeHnjbZR6KGGpYXnud5QhdW:3c3WgRnYzKGOnbHzzJIF{e2W|c3XkJIF{KG2jeHnteY0hdm:wLYTvfIlkKGOxbnPlcpRz[XSrb36gZYZ1\XJiMkSgbJJ{KGK7IF3UWEBie3OjeR?= NX7w[|RmOjN5MUG5NVc>

... Click to View More Cell Line Experimental Data

In vivo Indomethacin increases BrdU+ cells of all lineages and reduces microglial/monocyte activation in rats after focal cerebral ischemia. [2] Indomethacin (7.5 mg/kg, one injection) produces acute injury and inflammation in the distal jejunum and proximal ileum that are maximal at three days and completely resolves within one week. Indomethacin (two daily subcutaneous injections) produces a more extensive and chronic inflammation that lasts in an active form in more than 75% of the rats for at least two weeks. [3] Indomethacin (4ppm) reduces tumor yield by 78% in SKH:HR-1-hrBr hairless mice. [4] Indomethacin (20 mg/kg, orally) increases the total area of gastric erosions and concentration of lipid peroxides in the gastric mucosa of rats. Indomethacin increases the alpha-tocopherol:total cholesterol ratio in serum. Indomethacin inhibits the increases in gastric mucosal erosions and lipid peroxides in the gastric mucosa, and the reduction of serum alpha-tocopherol. [5]

Protocol

Solubility (25°C)

In vitro DMSO 72 mg/mL (201.23 mM)
Ethanol 24 mg/mL (67.07 mM)
Water Insoluble
In vivo Add solvents to the product individually and in order(Data is from Selleck tests instead of citations):
5% DMSO+30% PEG 300+5% Tween 80+ddH2O
For best results, use promptly after mixing.
2mg/mL

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 357.79
Formula

C19H16ClNO4

CAS No. 53-86-1
Storage powder
in solvent
Synonyms N/A

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment interventions Conditions Sponsor/Collaborators Start Date Phases
NCT04025177 Not yet recruiting Drug: Indomethacin Injection Patent Ductus Arteriosus After Premature Birth University of Manitoba|St. Boniface General Hospital Research Centre|Health Sciences Centre Winnipeg Manitoba|University at Buffalo January 2020 Phase 2

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

COX Signaling Pathway Map

Related COX Products

Tags: buy Indomethacin | Indomethacin supplier | purchase Indomethacin | Indomethacin cost | Indomethacin manufacturer | order Indomethacin | Indomethacin distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID